Blog Posts

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Scoping 340B Referral Capture Opportunity: It’s Bigger Than You Think

SPONSORED CONTENT

Imagine the services you could offer to the community your facility serves if you had additional funding. If you’re a 340B covered entity (CE), referral capture might just pave the way to securing those much-needed funds.

The 340B program provides essential funding

Read More »

Merck Fully Exempts West Virginia Providers From 340B Contract Pharmacy Restrictions

Drug manufacturer Merck announced it will end its 340B contract pharmacy restrictions in West Virginia.
Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bausch & Lomb Becomes 35th Manufacturer to Impose Contract Pharmacy Restrictions, Policy Applies to All 340B Entities

Canadian drug manufacturer Bausch & Lomb announced contract pharmacy restrictions that apply to all 340B covered entity types.
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Alkermes Is 36th Drugmaker to Implement Contract Pharmacy Restrictions, Sanofi Tightens Policy

Pharmaceutical manufacturer Alkermes is the 36th drugmaker to implement 340B contract pharmacy restrictions.
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Michigan Lawmakers, Witnesses Spar Over 340B Contract Pharmacy Access Bill in Key Hearing

Ben Frederick, associate vice president of advocacy and government relations at Memorial Healthcare, testified in support of a 340B contract pharmacy access bill at a Michigan state house hearing.
Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mount Sinai Reports 340B Pharmacy Revenue Losses in Early 2024

New York City-based Mount Sinai Hospital reported significantly decreased 340B pharmacy revenue at the start of 2024.
A major New York City hospital reported that decreased 340B pharmacy revenue helped drive millions in year-over-year losses in one [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Reform Could Generate Federal Savings, Says Consulting Firm That Has Conducted 340B Studies for Pharma Friendly Groups

Avalere's Milena Sullivan told 340B Report that it's important to understand "the impact 340B reform could have on federal spending."
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Manufacturers Announce Refunds to 340B Providers

Five drug manufacturers will refund 340B covered entities for certain drug overcharges.
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »